FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: StructureDefinition InclusionCriterias

Name	Flags	Card.	Type	Description & Constraints
InclusionCriterias		0..*	Base	Inclusion Criteria for Prostate Cancer Cohorts
psa		0..1	Quantity	Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.
dre		0..1	integer	Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).
Documentation for this format

Source1

{
  "resourceType": "StructureDefinition",
  "id": "InclusionCriterias",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "url": "http://hl7.eu/fhir/ig/flute/StructureDefinition/InclusionCriterias",
  "version": "0.1.0",
  "name": "InclusionCriterias",
  "title": "Inclusion Criteria for Prostate Cancer Cohorts",
  "status": "draft",
  "date": "2026-02-05T10:21:25+00:00",
  "publisher": "Flute Project",
  "contact": [
    {
      "name": "Flute Project",
      "telecom": [
        {
          "system": "url",
          "value": "https://www.fluteproject.eu/"
        }
      ]
    },
    {
      "name": "Flute Project",
      "telecom": [
        {
          "system": "url",
          "value": "https://www.fluteproject.eu/"
        }
      ]
    }
  ],
  "description": "Criteria for including men in cohorts based on clinical suspicion of prostate cancer.",
  "fhirVersion": "4.0.1",
  "mapping": [
    {
      "identity": "InclusionCriteriasToFHIR",
      "uri": "http://hl7.org/fhir/r4",
      "name": "Prostate Cancer Study Variables to FHIR R4 Profiles"
    }
  ],
  "kind": "logical",
  "abstract": false,
  "type": "http://hl7.eu/fhir/ig/flute/StructureDefinition/InclusionCriterias",
  "baseDefinition": "http://hl7.org/fhir/StructureDefinition/Base",
  "derivation": "specialization",
  "snapshot": {
    "extension": [
      {
        "url": "http://hl7.org/fhir/tools/StructureDefinition/snapshot-base-version",
        "valueString": "4.0.1"
      }
    ],
    "element": [
      {
        "id": "InclusionCriterias",
        "path": "InclusionCriterias",
        "short": "Inclusion Criteria for Prostate Cancer Cohorts",
        "definition": "Criteria for including men in cohorts based on clinical suspicion of prostate cancer.",
        "min": 0,
        "max": "*",
        "base": {
          "path": "Base",
          "min": 0,
          "max": "*"
        },
        "isModifier": false,
        "mapping": [
          {
            "identity": "InclusionCriteriasToFHIR",
            "map": "FHIR R4"
          }
        ]
      },
      {
        "id": "InclusionCriterias.psa",
        "path": "InclusionCriterias.psa",
        "short": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.",
        "definition": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.",
        "min": 0,
        "max": "1",
        "base": {
          "path": "InclusionCriterias.psa",
          "min": 0,
          "max": "1"
        },
        "type": [
          {
            "code": "Quantity"
          }
        ],
        "mapping": [
          {
            "identity": "InclusionCriteriasToFHIR",
            "map": "Observation.where(code = 'http://loinc.org|2857-1').value"
          }
        ]
      },
      {
        "id": "InclusionCriterias.dre",
        "path": "InclusionCriterias.dre",
        "short": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).",
        "definition": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).",
        "min": 0,
        "max": "1",
        "base": {
          "path": "InclusionCriterias.dre",
          "min": 0,
          "max": "1"
        },
        "type": [
          {
            "code": "integer"
          }
        ],
        "mapping": [
          {
            "identity": "InclusionCriteriasToFHIR",
            "map": "Procedure.where(code = 'http://snomed.info/sct|410006001').outcome"
          }
        ]
      }
    ]
  },
  "differential": {
    "element": [
      {
        "id": "InclusionCriterias",
        "path": "InclusionCriterias",
        "short": "Inclusion Criteria for Prostate Cancer Cohorts",
        "definition": "Criteria for including men in cohorts based on clinical suspicion of prostate cancer.",
        "mapping": [
          {
            "identity": "InclusionCriteriasToFHIR",
            "map": "FHIR R4"
          }
        ]
      },
      {
        "id": "InclusionCriterias.psa",
        "path": "InclusionCriterias.psa",
        "short": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.",
        "definition": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "Quantity"
          }
        ],
        "mapping": [
          {
            "identity": "InclusionCriteriasToFHIR",
            "map": "Observation.where(code = 'http://loinc.org|2857-1').value"
          }
        ]
      },
      {
        "id": "InclusionCriterias.dre",
        "path": "InclusionCriterias.dre",
        "short": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).",
        "definition": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).",
        "min": 0,
        "max": "1",
        "type": [
          {
            "code": "integer"
          }
        ],
        "mapping": [
          {
            "identity": "InclusionCriteriasToFHIR",
            "map": "Procedure.where(code = 'http://snomed.info/sct|410006001').outcome"
          }
        ]
      }
    ]
  }
}